Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,631
Closed -$11K 1998
2025
Q4
$11K Sell
1,631
-276
-14% -$1.87K ﹤0.01% 2372
2025
Q3
$12K Hold
1,907
﹤0.01% 2361
2025
Q2
$18K Hold
1,907
﹤0.01% 2147
2025
Q1
$23K Buy
1,907
+481
+34% +$6.29K ﹤0.01% 2008
2024
Q4
$16K Hold
1,426
﹤0.01% 2207
2024
Q3
$23K Hold
1,426
﹤0.01% 2072
2024
Q2
$15K Hold
1,426
﹤0.01% 2229
2024
Q1
$20K Sell
1,426
-4,196
-75% -$54.5K ﹤0.01% 2121
2023
Q4
$59K Sell
5,622
-344
-6% -$3.08K ﹤0.01% 2173
2023
Q3
$55K Hold
5,966
﹤0.01% 2216
2023
Q2
$43K Buy
5,966
+1,120
+23% +$9.66K ﹤0.01% 2387
2023
Q1
$41K Sell
4,846
-742
-13% -$6.71K ﹤0.01% 2381
2022
Q4
$42K Hold
5,588
﹤0.01% 2497
2022
Q3
$45K Buy
5,588
+88
+2% +$933 ﹤0.01% 2507
2022
Q2
$64K Buy
5,500
+78
+1% +$920 ﹤0.01% 2356
2022
Q1
$61K Buy
+5,422
New +$46.2K ﹤0.01% 2372

Other funds holding EOLS

Amalgamated Bank's EOLS Position: Q1 2026 in Review

Amalgamated Bank sold out of Evolus (EOLS) in Q1 2026, closing a stake of 1,631 shares — an estimated $11K sold.

Amalgamated Bank first reported a position in EOLS in Q1 2022 and held it in 16 quarters. The position peaked at $64K in Q2 2022. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Amalgamated Bank reported no remaining Evolus position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,631 Evolus shares in Q1 2026, an estimated $11K.
  • Amalgamated Bank first reported a position in Evolus in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Evolus position peaked at $64K in Q2 2022.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.